Literature DB >> 3132368

Role of intestinal anaerobic bacteria in colonization resistance.

C L Wells1, M A Maddaus, R P Jechorek, R L Simmons.   

Abstract

The purpose of this study was to clarify the role of the intestinal anaerobe bacteria in colonization resistance. Germfree mice were associated with Escherichia coli C25 and either (a) no other species; (b) enterococcus; (c) Escherichia coli M14 and Proteus mirabilis, or (d) Bacteroides fragilis and Bacteroides vulgatus. All species colonized the cecum in high numbers, but only enterococcus significantly limited the translocation of Escherichia coli C25 to mesenteric lymph nodes. However, the overall translocation rates were similar in all groups and ranged from 60% to 100%, due to translocation of other intestinal flora in addition to Escherichia coli C25. Conventionally reared mice were given either streptomycin, bacitracin/streptomycin or metronidazole which selectively eliminated facultative gram-negative bacteria, nearly all bacterial species or strictly anaerobic bacteria respectively. Only metronidazole significantly increased the rates of translocation of normal intestinal bacteria into mesenteric lymph nodes. Cohort groups of mice were then orally inoculated with drug resistant Escherichia coli C25, which actively colonized the cecum of all drug treated mice and translocated to the mesenteric lymph nodes of approximately half the streptomycin and metronidazole treated mice and nearly all the bacitracin/streptomycin treated mice. These results indicate that anaerobic bacteria play a pivotal role in limiting the translocation of normal intestinal bacteria, but that other bacterial groups also have a role in preventing the intestinal colonization and translocation of potential pathogens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132368     DOI: 10.1007/bf01962194

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Colonization resistance of the digestive tract of mice during systemic antibiotic treatment.

Authors:  D van der Waaij; J M Berghuis; J E Lekkerkerk
Journal:  J Hyg (Lond)       Date:  1972-12

2.  Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes.

Authors:  E K Steffen; R D Berg
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

3.  Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1972-06

4.  Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1971-09

5.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.

Authors:  M J Kennedy; P A Volz
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.

Authors: 
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

7.  Promotion by burn stress of the translocation of bacteria from the gastrointestinal tracts of mice.

Authors:  K Maejima; E Deitch; R Berg
Journal:  Arch Surg       Date:  1984-02

8.  Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model.

Authors:  R D Berg; A W Garlington
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.

Authors:  A W Dekker; M Rozenberg-Arska; J J Sixma; J Verhoef
Journal:  Ann Intern Med       Date:  1981-11       Impact factor: 25.391

10.  Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole.

Authors:  R D Berg
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

View more
  21 in total

Review 1.  Perspectives on bifidobacteria as biotherapeutic agents in gastrointestinal health.

Authors:  L C Duffy; A Leavens; E Griffiths; D Dryja
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 2.  Relationship between intestinal microecology and the translocation of intestinal bacteria.

Authors:  C L Wells
Journal:  Antonie Van Leeuwenhoek       Date:  1990-08       Impact factor: 2.271

3.  Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study.

Authors:  V G Alexiou; A Michalopoulos; G C Makris; G Peppas; G Samonis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

4.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

5.  Molecular characterization of fecal microbiota in patients with viral diarrhea.

Authors:  Chaofeng Ma; Xiaokang Wu; Muhammad Nawaz; Jinsong Li; Pengbo Yu; John E Moore; Jiru Xu
Journal:  Curr Microbiol       Date:  2011-07-08       Impact factor: 2.188

Review 6.  Is there a role for lactobacilli in prevention of urogenital and intestinal infections?

Authors:  G Reid; A W Bruce; J A McGroarty; K J Cheng; J W Costerton
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

7.  Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection.

Authors:  Amy Croswell; Elad Amir; Paul Teggatz; Melissa Barman; Nita H Salzman
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

8.  Oral bacteriotherapy for viral gastroenteritis.

Authors:  E Isolauri; M Kaila; H Mykkänen; W H Ling; S Salminen
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

9.  Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice.

Authors:  K A Krogfelt; L K Poulsen; S Molin
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Water-soluble ethylhydroxyethyl cellulose prevents bacterial translocation induced by major liver resection in the rat.

Authors:  X Wang; R Andersson; V Soltesz; W Guo; S Bengmark
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.